🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

CTV atlas from the early to mid-90s at Queen Elizabeth Hospital in HK. These maps were developed based on Prof John Ho’s observations during autopsies of patients who died of recurrence back in the 60s-80s. Truly an NPC master! David Sher Melvin LK CHUA | FRCR, PhD, FASCO Shing Fung Lee

Very proud to see this finally in press by my mentee and fellow Clinician-Scientist Kae Jack Tay In a domain where #FocalTherapy in #ProstateCancer remains controversial and divisive, progress can be made by good #Science Thks to the Decipher by Veracyte team Elai Davicioni

After 24h of ✈️🛫🛬 across 2 time zones… am finally at my hotel lobby for #ASCO2025 Always nice to be back in the windy city 😉

Can’t be more proud of Kevin Chua 🎉🎉 #BrothersinOncology #ASCO2025

Kicking off #ASCO2025 strong! #HeadNeckCancer session chaired by C. Jillian Tsai, MD, PhD 💪🏻💪🏻💪🏻 #Radiomics #Pathomics #NovelTreatment Great talks by Anant Madabhushi

#Oncologycomrades #ASCO2025 #FASCO Nice to be acknowledged for our voluntary work for ASCO Robin Zon, MD, FACP, FASCO Herbert Loong, MBBS, FASCO Rebecca Dent Quite an honour! A small bit goes a long way especially with friends!!

Further confirming that ASCO is truly a #global community! 🌍 Thanks everyone for working together in moving our field forward! Robin Zon, MD, FACP, FASCO Melvin LK CHUA | FRCR, PhD, FASCO Mark Lewis, MD, FASCO Vamsi Velcheti, MD MBA FASCO Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Aakash Desai, MD, MPH, FASCO #ASCO25 #FASCO #LCSM #Sarcoma #drugdevelopment #IAC #globalonc

Very powerful and insightful discussion by Prof Kevin Harrington The Royal Marsden Cancer Charity on KN-630 and C-POST The slides speak volumes and it isn’t just about the timing of anti-PD-1 😜 Sana Karam, MD, PhD C. Jillian Tsai, MD, PhD Sean McBride Pierre Blanchard, MD #ASCO2025 #Skincancer #Cutaneouscancer

#ASCO2025 #HeadNeckCancer #NasopharyngealCarcinoma This is going to be provocative Toripalimab and concurrent RT, replacing CDDP in LA-NPC showing equipoise Any comments on this approach? Sana Karam, MD, PhD 😜

Fantastic reception at the JAMA JAMA Oncology 10y celebration in downtown Chicago! The history is impeccable and the views are even better! #ASCO2025

Several promising targets in #HeadNeckCancer BCA101 targeting HPV- population looks exciting and glad to be involved in the steering committee of FORTFI-HN01 The deep responses esp for the CPS1-19 subset are exciting! Much to learn about the #HeadNeckBiology Sana Karam, MD, PhD

The field of #HeadNeckCancer just got more interesting! #ASCO2025 #Plenary NIVO-POSTOP study was an important IIS for high risk HNSCC Positive DFS @ 3y But signal is primarily locoregional control! Stark contrast to KN689 Kudos to GORTEC Pierre Blanchard, MD Thoughts??

#ASCO2025 #PresidentReception Learning something from the 🤴 of #selfies Petros Grivas Kevin Chua Such a great gathering of people and I can’t help but promote #ASCOBT2026 #ASCOBreakthrough when you have Singapore sling as a cocktail drink!

Here are the top trials from day 3 of ASCO 2025. Follow us and get the latest #ASCO25 updates: t.ly/7TCD6 #LARVOL #ASCO2025 #CancerResearch #Oncology #ClinicalTrials #CancerData #CancerCare | Harold J. Burstein, MD, PhD, FASCO | Pashtoon Kasi MD, MS | Arndt Vogel | Melvin LK CHUA | FRCR, PhD, FASCO | Stephen V Liu, MD |